Growing mismatch between antibacterial innovation...

Growing mismatch between antibacterial innovation and global patient needs

20.07.2022: The recently published update of WHO’s analyses of the global clinical antibacterial pipeline, now integrated within the Global AMR R&D Hub’s Dynamic Dashboard, again highlights a major gap in the development of needed new innovative antibiotics to address growing public health needs globally. Click to find out more.

Latest news

Go to all news

AI panel at the 8th AMR Conference in Basel

8th AMR Conference

On the 6-7th March 2024, the Hub team was delighted to participate in the 8th AMR Conference in Basel, as well as host a thought provoking session on AI...

EU-JAMRAI 2 Meeting: European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections

On February 13, 2024, over 100 partners and stakeholders from 30 European countries gathered in Paris to kickstart the second Joint Action...

Antimicrobial Chemotherapy Conference

Producing a new antibiotic is a laborious, risky and expensive process. It typically takes 10 - 15 years and over USD 1 billion. How can we incentivise research and development...

Evidence for Action Dialogue on Antimicrobial Resistance

The inaugural Evidence for Action (E4A) Dialogue on Antimicrobial Resistance (AMR) was hosted by Hon. Dr. Chris Fearne MP, Deputy Prime Minister of Malta...

Dynamic Dashboard